Wei‐Ting Chang
Impact in
-
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
- Internal Medicine top 10%
Papers in
-
- Cardiovascular Function and Risk Factors 27
- Chemotherapy-induced cardiotoxicity and mitigation 16
- Heart Failure Treatment and Management 12
-
- Ion channel regulation and function 11
- Co-authors
- Zhih‐Cherng Chen (48 shared papers)Sheng‐Nan Wu (16 shared papers)Chia‐Te Liao (24 shared papers)Ping‐Yen Liu (21 shared papers)Han Siong Toh (17 shared papers)Jhih‐Yuan Shih (26 shared papers)Wen‐Liang Yu (3 shared papers)Juei‐Tang Cheng (7 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)PLoS ONE (6 papers)Frontiers in Cardiovascular Medicine (5 papers)Journal of the American Heart Association (4 papers)ESC Heart Failure (4 papers)
- Partner nations
- TaiwanUnited StatesBelgium
In The Last Decade
Wei‐Ting Chang
144 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 136
- Cardiology and Cardiovascular Medicine 738
- Internal Medicine 63
- Endocrinology, Diabetes and Metabolism 217
- Virology 53
- Toxicology 30
Countries citing papers authored by Wei‐Ting Chang
This map shows the geographic impact of Wei‐Ting Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Chang more than expected).
Fields of papers citing papers by Wei‐Ting Chang
This network shows the impact of papers produced by Wei‐Ting Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Chang. The network helps show where Wei‐Ting Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ting Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 141 | |
| 2 | 2020 | 97 | |
| 3 | 2015 | 77 | |
| 4 | 2015 | 72 | |
| 5 | 2022 | 68 | |
| 6 | 2020 | 57 | |
| 7 | 2019 | 43 | |
| 8 | 2022 | 43 | |
| 9 | 2017 | 43 | |
| 10 | 2021 | 40 | |
| 11 | 2021 | 36 | |
| 12 | 2016 | 35 | |
| 13 | 2016 | 33 | |
| 14 | 2022 | 32 | |
| 15 | 2020 | 32 | |
| 16 | 2016 | 32 | |
| 17 | 2011 | 31 | |
| 18 | 2021 | 29 | |
| 19 | 2017 | 29 | |
| 20 | 2022 | 27 |
About Wei‐Ting Chang
Wei‐Ting Chang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 155 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (27 papers), Chemotherapy-induced cardiotoxicity and mitigation (16 papers), Cardiac Imaging and Diagnostics (13 papers), Heart Failure Treatment and Management (12 papers), Pulmonary Hypertension Research and Treatments (11 papers), Ion channel regulation and function (11 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Diabetes Treatment and Management (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (738 citations), Internal Medicine (63 citations), Endocrinology, Diabetes and Metabolism (217 citations), Virology (53 citations) and Toxicology (30 citations). Wei‐Ting Chang has collaborated with scholars based in Taiwan, United States and Belgium. Frequent co-authors include Zhih‐Cherng Chen, Sheng‐Nan Wu, Chia‐Te Liao, Ping‐Yen Liu, Han Siong Toh, Jhih‐Yuan Shih, Wen‐Liang Yu, Juei‐Tang Cheng, Chung‐Han Ho and Yu‐Wen Lin. Their work appears in journals such as International Journal of Molecular Sciences, PLoS ONE, Frontiers in Cardiovascular Medicine, Journal of the American Heart Association and ESC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.